Nos­trum agrees to $50M set­tle­ment with DOJ over al­le­ga­tions of un­der­pay­ing Med­ic­aid

Mis­souri-based phar­ma Nos­trum Lab­o­ra­to­ries and its CEO have agreed to pay a min­i­mum $3.8 mil­lion and up to $50 mil­lion to set­tle ac­cu­sa­tions from the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.